Key questions (and answers) about the historic approval of a CRISPR-based medicine

By STAT News
| November 17, 2023

For the first time, a regulator has cleared a treatment using CRISPR, the gene-editing technology, for patients.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...